Clin2
NCT06694558Possibly a fitRecruiting

Monocytes in type 1 diabetes and kidney disease study

Chronic Kidney Disease(CKD)Type 1 Diabetes (T1D)

Part of Hormones & metabolism, Immune system & allergy, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study looks at immune cells (monocytes) in people with type 1 diabetes, with or without early kidney problems. Researchers want to understand how these cells differ between groups. You may be able to join if you have type 1 diabetes and use an insulin pump or injections along with a continuous glucose monitor (CGM).

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 65 years
Study type
Observational

Who can take part

  • You are between 18 and 65 years old
  • You have been diagnosed with type 1 diabetes
  • You use insulin injections or an insulin pump
  • You use a continuous glucose monitor (CGM)
  • You have either early kidney disease or normal kidney function
  • You are not currently using certain diabetes medications like GLP-1 agonists, DPP4 inhibitors, or SGLT2 inhibitors

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07051564Recruiting
Cell injection study for type 1 diabetes

This trial tests a new cell injection (CNK-UT009) for adults with type 1 diabetes. The goal is to see if it can help manage blood sugar and reduce insulin needs.

Zibo, Shandong
NCT07503366Not yet recruiting
Italian study tracks people with early type 1 diabetes risk markers

This study follows people of all ages who have a positive islet autoantibody test but no diabetes symptoms yet. It aims to track them over time to learn more about how type 1 diabetes develops, which may lead to better prevention and care.

Ancona
NCT07594145Not yet recruiting· Phase 2
New treatments for heart and kidney problems in type 1 diabetes

This study tests new treatments for people with long-standing type 1 diabetes who also have early signs of heart or kidney disease. The goal is to see if these treatments can help protect the heart and kidneys.

Ann Arbor, Michigan
NCT07592000Recruiting· Phase 1/Phase 2
New Treatment for Type 1 Diabetes With Kidney Disease

This study tests a new experimental medication for people with type 1 diabetes who experience dangerous low blood sugar episodes and have early-stage kidney disease. The trial aims to help improve blood sugar control and reduce these risky episodes.

Miami, Florida
NCT07270172Recruiting
Micronutrient study for type 1 diabetes complications

This study tests how a specific drug affects heart and kidney health in people with type 1 diabetes who already have some complications like kidney disease, heart problems, or obesity. It aims to find new ways to prevent further damage.

Aarhus N
NCT07144696Recruiting
Study to improve metabolic health in type 1 diabetes

This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.

Beijing

Hear when a new Chronic Kidney Disease(CKD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.